Company / Free Cash Flow per Share
Immunocore Holdings plc Free Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.30
FY2025
5-year range
-$3.40 / $0.42
FY2021-FY2025
Trend
-171.6%
vs FY2024
Sector context
#76 of 192
Health Care
What the data says
At $-0.30, Immunocore Holdings plc's free cash flow per share ranks #76 of 192 in the Health Care sector. Declined from $-0.05 to $-0.30 over the past 2 years.
Based on SEC 10-K filings.
-0.30 in FY2025.
Declined from $-0.05 to $-0.30 over the past 2 years.
Health Care sector context is included.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#76 of 192 in Health CareTop 40% of 192This company -$0.30 Sector average -$19.84
▼
+98.5% above sector average
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 171.6% year-over-year.
- Ranks #76 out of 192 companies in the Health Care sector.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.5%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$0.30 | -171.6% |
| FY2024 | $0.42 | +912.9% |
| FY2023 | -$0.05 | +95.4% |
| FY2022 | -$1.12 | +66.9% |
| FY2021 | -$3.40 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026